Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Capital Expenditures (2022 - 2025)

Phathom Pharmaceuticals (PHAT) has disclosed Capital Expenditures for 4 consecutive years, with $178000.0 as the latest value for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 3460.0% year-over-year to $178000.0; the TTM value through Mar 2026 reached $211000.0, up 44.52%, while the annual FY2025 figure was $229000.0, 69.63% up from the prior year.
  • Capital Expenditures hit $178000.0 in Q4 2025 for Phathom Pharmaceuticals, up from -$64000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $939000.0 in Q3 2023 and bottomed at -$1.1 million in Q4 2023.
  • Average Capital Expenditures over 4 years is $32500.0, with a median of $12500.0 recorded in 2024.
  • On a YoY basis, Capital Expenditures climbed as much as 3460.0% in 2025 and fell as far as 153.33% in 2025.
  • Phathom Pharmaceuticals' Capital Expenditures stood at -$491000.0 in 2022, then crashed by 132.38% to -$1.1 million in 2023, then soared by 100.44% to $5000.0 in 2024, then surged by 3460.0% to $178000.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $178000.0, -$64000.0, and $97000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.